Benutzer: Gast  Login
Dokumenttyp:
journal article 
Autor(en):
Heck, MM; Thalgott, M; Retz, M; Wolf, P; Maurer, T; Nawroth, R; Hatzichristodoulou, G; Gschwend, JE; Kübler, H 
Titel:
Rational indication for docetaxel rechallenge in metastatic castration-resistant prostate cancer. 
Abstract:
Study Type - Therapy (case series) Level of Evidence 4 What's known on the subject? and What does the study add? Docetaxel rechallenge has shown preserved anti-tumour activity and has therefore been proposed as an option for further treatment in patients with metastatic castration-resistant prostate cancer, who have shown a good response to first-line chemotherapy with docetaxel. The present study provides evidence of docetaxel activity in patients who were treated with full-dose (75 mg/m ) 3-we...    »
 
Zeitschriftentitel:
BJU Int 
Jahr:
2012 
Band / Volume:
110 
Heft / Issue:
11 Pt B 
Seitenangaben Beitrag:
E635-40 
Sprache:
eng 
Print-ISSN:
1464-4096 
TUM Einrichtung:
Urologische Klinik und Poliklinik; r Medizinische Statistik und Epidemiologie